{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:40:23Z","timestamp":1776170423859,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This project was partly funded by the Weill Cornell Medical College Dean\u2019s Diversity and Healthcare Disparity Research Award"},{"name":"This project was partly funded by the Weill Cornell Medical College Dean\u2019s Diversity and Healthcare Disparity Research Award."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,5,5]]},"DOI":"10.1038\/s41416-026-03380-7","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:59:18Z","timestamp":1773485958000},"page":"1325-1335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of social drivers of health on delayed time to breast cancer surgery"],"prefix":"10.1038","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3273-1970","authenticated-orcid":false,"given":"Shadi","family":"Azam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjile","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin H.","family":"Kensler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark G.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Mount","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Bea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-8668","authenticated-orcid":false,"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"3380_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345.","journal-title":"CA Cancer J Clin"},{"key":"3380_CR2","first-page":"438","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69:438\u201351.","journal-title":"CA Cancer J Clin"},{"key":"3380_CR3","doi-asserted-by":"publisher","first-page":"e185113","DOI":"10.1001\/jamasurg.2018.5113","volume":"154","author":"YL Eaglehouse","year":"2019","unstructured":"Eaglehouse YL, Georg MW, Shriver CD, Zhu K. Racial differences in time to breast cancer surgery and overall survival in the US Military Health System. JAMA Surg. 2019;154:e185113.","journal-title":"JAMA Surg"},{"key":"3380_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jamasurg.2022.8388","volume":"158","author":"AA Wiener","year":"2023","unstructured":"Wiener AA, Hanlon BM, Schumacher JR, Vande Walle KA, Wilke LG, Neuman HB. Reexamining time from breast cancer diagnosis to primary breast surgery. JAMA Surg. 2023;158:485\u201392.","journal-title":"JAMA Surg"},{"key":"3380_CR5","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1245\/s10434-015-4397-3","volume":"22","author":"VB Sheppard","year":"2015","unstructured":"Sheppard VB, Oppong BA, Hampton R, Snead F, Horton S, Hirpa F, et al. Disparities in breast cancer surgery delay: the lingering effect of race. Ann Surg Oncol. 2015;22:2902\u201311.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR6","first-page":"2566","volume":"120","author":"A DeGroff","year":"2014","unstructured":"DeGroff A, Royalty JE, Howe W, Buckman DW, Gardner J, Poister T, et al. When performance management works: a study of the National Breast and Cervical. Cancer Early Detect Program Cancer. 2014;120:2566\u201374.","journal-title":"Cancer Early Detect Program Cancer"},{"key":"3380_CR7","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/cncr.28821","volume":"120","author":"B Yancy","year":"2014","unstructured":"Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Using data to effectively manage a national screening program. Cancer. 2014;120:2575\u201383.","journal-title":"Cancer"},{"key":"3380_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1089\/jwh.2014.4773","volume":"24","author":"P George","year":"2015","unstructured":"George P, Chandwani S, Gabel M, Ambrosone CB, Rhoads G, Bandera EV, et al. Diagnosis and surgical delays in African American and white women with early-stage breast cancer. J Women\u2019s Health. 2015;24:209\u201317.","journal-title":"J Women\u2019s Health"},{"key":"3380_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.674736","volume":"9","author":"S Gehlert","year":"2021","unstructured":"Gehlert S, Hudson D, Sacks T. A critical theoretical approach to cancer disparities: breast cancer and the social determinants of health. Front Public Health. 2021;9:674736.","journal-title":"Front Public Health"},{"key":"3380_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/COC.0000000000000914","volume":"45","author":"BS Venkataramany","year":"2022","unstructured":"Venkataramany BS, Sutton JM. Social determinants of health in oncology: towards a more personalized and equitable delivery of cancer care. Am J Clin Oncol. 2022;45:273\u20138.","journal-title":"Am J Clin Oncol"},{"key":"3380_CR11","unstructured":"INSIGHT Clinical Research Network. https:\/\/insightcrn.org\/our-data\/."},{"key":"3380_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/amiajnl-2014-002764","volume":"21","author":"R Kaushal","year":"2014","unstructured":"Kaushal R, Hripcsak G, Ascheim DD, Bloom T, Campion TR Jr., Caplan AL, et al. Changing the research landscape: the New York City Clinical Data Research Network. J Am Med Inf Assoc. 2014;21:587\u201390.","journal-title":"J Am Med Inf Assoc"},{"key":"3380_CR13","unstructured":"Shang N, Hripcsak G, Weng C, Chung W, Crew KA. KnowledgeBase for Discovering Phenotypes from Electronic Medical Records - Breast Cancer 2019."},{"key":"3380_CR14","unstructured":"Comorbidity SAS Macro (2021 version). National Cancer Institute, Division of Cancer Control & Population Sciences 2021."},{"key":"3380_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"3380_CR16","unstructured":"U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Social Determinants of Health. Healthy People 2030. Available at: https:\/\/health.gov\/healthypeople\/objectives-and-data\/social-determinants-health (Accessed October 2025)."},{"key":"3380_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/01621459.1992.10475190","volume":"87","author":"J Fox","year":"1992","unstructured":"Fox J, Monette G. Generalized collinearity diagnostics. J Am Stat Assoc. 1992;87:178\u201383.","journal-title":"J Am Stat Assoc"},{"key":"3380_CR18","unstructured":"National Cancer Institute, Division of Cancer Control and Population Sciences, Joinpoint Trend Analysis Software 2025."},{"key":"3380_CR19","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.1245\/s10434-022-11834-4","volume":"29","author":"RJ Zipkin","year":"2022","unstructured":"Zipkin RJ, Schaefer A, Wang C, Loehrer AP, Kapadia NS, Brooks GA, et al. Rural-urban differences in breast cancer surgical delays in medicare beneficiaries. Ann Surg Oncol. 2022;29:5759\u201369.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR20","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1002\/cncr.33121","volume":"126","author":"MA Emerson","year":"2020","unstructured":"Emerson MA, Golightly YM, Aiello AE, Reeder-Hayes KE, Tan X, Maduekwe U, et al. Breast cancer treatment delays by socioeconomic and health care access latent classes in Black and White women. Cancer. 2020;126:4957\u201366.","journal-title":"Cancer"},{"key":"3380_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.amjsurg.2023.05.024","volume":"226","author":"Y-W Chen","year":"2023","unstructured":"Chen Y-W, Kim T, Specht MC, Gadd MA, Smith BL, Chang DC, et al. Time to surgery: a health equity metric in breast cancer patients. Am J Surg. 2023;226:432\u20137.","journal-title":"Am J Surg"},{"key":"3380_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330\u20139.","journal-title":"JAMA Oncol"},{"key":"3380_CR23","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1200\/JCO.22.00519","volume":"40","author":"SH Giordano","year":"2022","unstructured":"Giordano SH, Franzoi MAB, Temin S, Anders CK, Chandarlapaty S, Crews JR, et al. Systemic therapy for advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO guideline update. J Clin Oncol. 2022;40:2612\u201335.","journal-title":"J Clin Oncol"},{"key":"3380_CR24","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1200\/JCO.2014.56.7479","volume":"32","author":"AH Partridge","year":"2014","unstructured":"Partridge AH, Rumble RB, Carey LA, Come SE, Davidson NE, Di Leo A, et al. Chemotherapy and targeted therapy for women with human epidermal growth factor receptor 2-negative (or unknown) advanced breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2014;32:3307\u201329.","journal-title":"J Clin Oncol"},{"key":"3380_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00565-1","volume":"12","author":"K Zhu","year":"2024","unstructured":"Zhu K, Yang X, Tai H, Zhong X, Luo T, Zheng H. HER2-targeted therapies in cancer: a systematic review. Biomark Res. 2024;12:16.","journal-title":"Biomark Res"},{"key":"3380_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jss.2019.10.028","volume":"247","author":"E Siegel","year":"2020","unstructured":"Siegel E, Tseng J, Giuliano A, Amersi F, Alban RF. Treatment at academic centers increases likelihood of reconstruction after mastectomy for breast cancer patients. J Surg Res. 2020;247:156\u201362.","journal-title":"J Surg Res"},{"key":"3380_CR27","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/PRS.0b013e3181f444bc","volume":"126","author":"WH Tseng","year":"2010","unstructured":"Tseng WH, Stevenson TR, Canter RJ, Chen SL, Khatri VP, Bold RJ, et al. Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum. Plast Reconstr Surg. 2010;126:1815\u201324.","journal-title":"Plast Reconstr Surg"},{"key":"3380_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jamcollsurg.2019.12.005","volume":"230","author":"KM Corey","year":"2020","unstructured":"Corey KM, Helmkamp J, Simons M, Curtis L, Marsolo K, Balu S, et al. Assessing quality of surgical real-world data from an automated electronic health record pipeline. J Am Coll Surg. 2020;230:295\u2013305.e12.","journal-title":"J Am Coll Surg"},{"key":"3380_CR29","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1245\/s10434-025-17843-3","volume":"32","author":"G Martin","year":"2025","unstructured":"Martin G, Kensler KH, An A, Gemson E, Mount L, Tamimi RM, et al. Closing the gap: disparities in breast reconstruction after mastectomy. Ann Surg Oncol. 2025;32:8313\u201322.","journal-title":"Ann Surg Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03380-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03380-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03380-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T11:40:20Z","timestamp":1776166820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03380-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,5,5]]}},"alternative-id":["3380"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03380-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,14]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This retrospective analysis was approved through the Biomedical Research Alliance of New York\u2019s Central Institutional Review Board (IRB), providing regulatory oversight for institutions using the Weill Research Gateway. Weill Cornell Medicine is part of the Streamlined, Multisite, Accelerated Resources for Trials (SMART) IRB network, supporting multi-site IRB reviews for national studies. Research activities using INSIGHT CRN data are also conducted under the umbrella of The National Patient-Centered Clinical Research Network\u2019s Central IRB approval and INSIGHT\u2019s Data Use Agreement. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}